MYFORTIC 360mg gastro-resistant tablets medication leaflet

L04AA06 mycophenolate • Antineoplastic and immunomodulating agents | Immunosuppressants | Selective immunosuppressants

Mycophenolate is an immunosuppressive medication used to prevent organ rejection in transplant recipients, such as kidney, liver, or heart transplants. It is often used in combination with other immunosuppressive drugs, such as cyclosporine and corticosteroids. Mycophenolate works by inhibiting the proliferation of T and B lymphocytes, thereby reducing the immune response against the transplanted organ.

Mycophenolate is available as mycophenolate mofetil (MMF) or mycophenolate sodium (MPS), both of which are taken orally, usually twice daily, as directed by a doctor. The exact dosage depends on the type of transplant and the patient’s condition.

Common side effects include nausea, diarrhea, vomiting, abdominal pain, and infections, as the medication suppresses the immune system. Other side effects may include anemia, leukopenia (low white blood cell count), and an increased risk of severe or opportunistic infections.

Mycophenolate is contraindicated in pregnant women, as it can cause severe birth defects. Women of childbearing age must use effective contraception during treatment and for several weeks after stopping the medication. Regular monitoring is essential to detect potential side effects and adjust the dosage if necessary.

General data about MYFORTIC 360mg

Substance: mycophenolate

Date of last drug list: 01-06-2025

Commercial code: W70689003

Concentration: 360mg

Pharmaceutical form: gastro-resistant tablets

Quantity: 120

Product type: original

Price: 701.13 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: NOVARTIS PHARMA GMBH - GERMANIA

Holder: NOVARTIS EUROPHARM LIMITED - IRLANDA

Number: 8650/2016/03

Shelf life: 36 months

Concentrations available for mycophenolate

180mg, 1g/5ml, 360mg, 500mg

Compensation lists for MYFORTIC 360mg EUROPHARM

NHP 9.1 (C2) - Spinal cord transplant

Price

Copayment

Patient

701.13 RON

701.13 RON

0.00 RON

NHP 9.2 (C2) - Heart transplant

Price

Copayment

Patient

701.13 RON

701.13 RON

0.00 RON

NHP 9.3 (C2) - Liver Transplant

Price

Copayment

Patient

701.13 RON

701.13 RON

0.00 RON

NHP 9.4 (C2) - Kidney transplant, combined kidney and pancreas transplant

Price

Copayment

Patient

701.13 RON

701.13 RON

0.00 RON

NHP 9.6 (C2) - Lung transplant

Price

Copayment

Patient

701.13 RON

701.13 RON

0.00 RON

NHP 9.7 (C2) - Outpatient treatment of transplant patients

Price

Copayment

Patient

701.13 RON

701.13 RON

0.00 RON